C-Reactive Protein, but Not Low-Density Lipoprotein Cholesterol Levels, Associate with Coronary Atheroma Regression and Cardiovascular Events Following Maximally Intensive Statin Therapy

Study Questions:

Baseline C-reactive protein (CRP) levels predict major adverse cardiovascular events (MACE) (death, myocardial infarction, stroke, coronary revascularization, and hospitalization for unstable angina). Is there an association between changes in CRP levels with plaque progression and MACE in the setting of maximally intensive statin therapy?